Explain Why Patients Shouldn't Wait to Get Shingrix Instead of Zostavax II

There's buzz about a new zoster vaccine in the pipeline that's tentatively called Shingrix (SHING-riks).

Explain that it probably won't be approved until late 2017 at best.

But it's already making headlines...because it seems to work better than Zostavax II to prevent shingles.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote